BioNTech stock quote 18-9-2020
Company: BioNTechTicker: BNTXExchange: NASDAQLast Trade: $67.00Change: 0.22% Change: +0.33%Volume: 2,607,052Day’s High: $68.44Day’s Low: $65.17Previous Close: $66.78 Service provided by Intrado Digital Media, LLC
Month: September 2020
BioNTech stock quotation September 17, 2020
Company: BioNTechTicker: BNTXExchange: NASDAQLast Trade: $66.78Change: 0.74% Change: +1.12%Volume: 2,852,215Day’s High: $68.71Day’s Low: $65.15Previous Close: $66.04
BioNTech stock quote 16-9-2020
Company: BioNTechTicker: BNTXExchange: NASDAQLast Trade: $66.04Change: -0.88% Change: -1.32%Volume: 2,230,529Day’s High: $67.29Day’s Low: $65.41Previous Close: $66.92
BioNTech stock quote 15-9-2020
BioNTech stock quote 15-9-2020 Company: BioNTechTicker: BNTXExchange: NASDAQLast Trade: $66.92Change: -0.56% Change: -0.83%Volume: 3,161,892Day’s High: $70.00Day’s Low: $66.15Previous Close: $67.48
Bayer Launches Large-scale Pre-launch Trial of New Tomato Varieties with Resistance to Tomato Brown Rugose Fruit Virus (ToBRFV)
The trials, which begin late September in Mexico, will target two varieties of Roma tomatoes which show little or no symptoms of ToBRFV / Developing […]
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic […]
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that it will receive a grant of up to 375 million Euro from an initiative […]
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that they have submitted an amended protocol to the U.S. Food and Drug […]
Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients
• Immunocompromised transplant patients are at risk of major complications when infected with BK virus • cobas BKV test addresses critical need for hospitals and […]
State aid: EU Commission approves €199.45 million Italian support to compensate Alitalia for damages suffered due to coronavirus outbreak
The European Commission has found Italian €199.45 million support in favour of Alitalia to be in line with EU State aid rules. The measure aims […]
Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems
• First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single […]
Merck Places Hybrid Bond Amounting to €1.0 billion
Merck, a leading science and technology company, today successfully placed a hybrid bond amounting to €1.0 billion. The placement has a maturity of 60 years […]
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care
• Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions • Antigen test accurately […]
Influenza Season 2020/21 – First Vaccine Batches Released
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines started the annual batch release testing of influenza vaccines on 31 July 2020. In the meantime, the […]
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
• 2025 target to increase patients reached in LMICs with strategic innovative medicines by 200% and the Novartis Flagship Programs by 50% – bringing potential […]